You have 9 free searches left this month | for more free features.

Booster dose

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

COVID-19 Trial in Adelaide (SpikoGen vaccine)

Not yet recruiting
  • COVID-19
  • SpikoGen vaccine
  • Adelaide, South Australia, Australia
    ARASMI
Sep 13, 2022

COVID-19 Trial in Wong Chuk Hang (COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose), COVID-19 Vaccine (Vero Cell),

Suspended
  • COVID-19
  • COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)
  • COVID-19 Vaccine (Vero Cell), Inactivated (High-dose)
  • Wong Chuk Hang, HongKong, China
    Gleneagles Hospital HongKong
Aug 9, 2022

Group B Streptococcus Infection Trial in Merthyr Tydfil (GBS-NN/NN2)

Completed
  • Group B Streptococcus Infection
  • GBS-NN/NN2
  • Merthyr Tydfil, Wales, United Kingdom
    Simbec Clinical Pharmacology
Aug 24, 2022

Covid-19 Vaccine Trial (PIKA COVID-19 vaccine)

Not yet recruiting
  • Covid-19 Vaccine
  • PIKA COVID-19 vaccine
  • (no location specified)
Jul 17, 2022

COVID-19 Trial in Peshawar (Medium-dosage COVID-19 Vaccine,Inactivated, High-dosage COVID-19 Vaccine,Inactivated,

Suspended
  • COVID-19
  • Medium-dosage COVID-19 Vaccine,Inactivated
  • +2 more
  • Peshawar, Pakistan
    Central Park Teaching Hospital
Aug 9, 2022

SARS-CoV-2 Infection Trial in Australia (ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001))

Recruiting
  • SARS-CoV-2 Infection
  • ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001)
  • Kanwal, New South Wales, Australia
  • +5 more
Nov 16, 2022

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

COVID-19 Respiratory Infection Trial in India (BBV154 Intranasal Vaccine, Intramuscular vaccine COVAXIN, Covishield)

Completed
  • COVID-19 Respiratory Infection
  • BBV154 Intranasal Vaccine
  • +2 more
  • Patna, Bihar, India
  • +8 more
Oct 1, 2022

COVID-19 Breakthrough Infection in Fully Vaccinated People and

Enrolling by invitation
  • COVID-19 Pneumonia
  • COVID-19
  • Pfizer COVID-19 mRNA vaccine
  • Moderna COVID-19 mRNA vaccine
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

LUF - Luteinised Unruptured Follicle Syndrome Trial in Tanta (hCG, Saline Solution)

Completed
  • LUF - Luteinised Unruptured Follicle Syndrome
  • hCG
  • Saline Solution
  • Tanta, Algharbia, Egypt
    Ayman Shehata Dawood
Feb 3, 2022

COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)

Active, not recruiting
  • COVID-19
  • NVX-CoV2373
  • SARS-CoV-2 rS antigen/Matrix-M Adjuvant
  • Austin, Texas
  • +4 more
May 16, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

COVID-19 Vaccines Trial in Marshfield (Reminder/Recall Sent Via Preferred Method of Communication)

Active, not recruiting
  • COVID-19 Vaccines
  • Reminder/Recall Sent Via Preferred Method of Communication
  • Marshfield, Wisconsin
    Marshfield Clinic Health System
Oct 10, 2022

COVID-19 Trial in Barranquilla (Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron

Not yet recruiting
  • COVID-19
  • Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Barranquilla, Colombia
    Clinica de la Costa
Jun 23, 2022

COVID-19 Trial in Campo Grande, Karachi (Sinovac, AZD1222, BNT162b2)

Recruiting
  • COVID-19
  • Sinovac
  • +2 more
  • Campo Grande, MS Do Sul, Brazil
  • +1 more
Jul 25, 2022

Second Booster Dose of Vaccine Against COVID-19 in Elderly

Not yet recruiting
  • COVID-19
  • +2 more
  • ChAdOx1 nCoV-19 or Comirnaty or Janssen COVID-19 Vaccine
  • Vitória, Espírito Santo, Brazil
    Valéria Valim
Mar 15, 2022

Hepatitis B Vaccine Trial (20 µg dose hepatitis B vaccine)

Not yet recruiting
  • Hepatitis B Vaccine
  • 20 µg dose hepatitis B vaccine
  • (no location specified)
Dec 2, 2021

Coronavirus Infections, Healthy Trial in Valinhos (NDV-HXP-S 10µg, BNT162b2 30µg)

Not yet recruiting
  • Coronavirus Infections
  • Healthy
  • NDV-HXP-S 10μg
  • BNT162b2 30μg
  • Valinhos, São Paulo, Brazil
    Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
May 16, 2022

Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory

Recruiting
  • Double Vaccinated for COVID-19 (For Phase 1 of the Study)
  • Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
  • COVAC-2
  • Saline Placebo
  • Burlington, Ontario, Canada
  • +2 more
Aug 24, 2022

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)

Active, not recruiting
  • Covid19
  • BNT162b2 vaccine
  • JNJ-78436735 Vaccine
  • Miami, Florida
    University of Miami
Aug 1, 2022

Virus Diseases Trial in Hradec Kralove (Encepur Adults)

Completed
  • Virus Diseases
  • Encepur Adults
  • Hradec Kralove, Czechia
    GSK Investigational Site
Jul 4, 2022